Licensing procedures for immunological veterinary medicinal products in the European Union.
With the adoption of the new authorization system, all regulatory needs for veterinary medicinal products have been fulfilled with the European Union. This system, indeed, provides access to a continent-wide market to innovative products, in particular vaccines, and facilitates access to the markets of the Member States for other products. This should have a clearly favorable impact on the veterinary vaccines industry.
Pastoret
P P
PP
Department of Immunology-Vaccinology, Faculty of Veterinary Medicine, University of Liège, Sart Tilman, Belgium.
Falize
F
F
D000818:Animals; D005060:Europe; D005062:European Union; D006734:Horse Diseases / Q000276:immunology; D006736:Horses; D007252:Influenza Vaccines / Q000592:standards; D007886:Legislation, Veterinary; D008009:Licensure, Pharmacy / Q000331:legislation & jurisprudence*; D009976:Orthomyxoviridae Infections / Q000276:immunology / Q000662:veterinary; D010602:Pharmacopoeias as Topic; D014612:Vaccines / Q000592:standards*
D007252:Influenza Vaccines; D014612:Vaccines